Now, researchers are testing an immunotherapy treatment they say is highly effective for patients with cancer that spreads or comes back.
| Benzinga
Puma Biotechnology Inc (NASDAQ: PBYI) popped 88 percent Monday on news that its neratinib candidate, an early-stage breast cancer treatment for human ...
No comments:
Post a Comment